Does PEGCETACOPLAN Cause Pulmonary embolism? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Pulmonary embolism have been filed in association with PEGCETACOPLAN (Empaveli). This represents 0.9% of all adverse event reports for PEGCETACOPLAN.
12
Reports of Pulmonary embolism with PEGCETACOPLAN
0.9%
of all PEGCETACOPLAN reports
11
Deaths
12
Hospitalizations
How Dangerous Is Pulmonary embolism From PEGCETACOPLAN?
Of the 12 reports, 11 (91.7%) resulted in death, 12 (100.0%) required hospitalization, and 3 (25.0%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGCETACOPLAN. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does PEGCETACOPLAN Cause?
Fatigue (135)
Visual impairment (125)
Haemoglobin decreased (106)
Haemolysis (100)
Off label use (97)
Vitreous floaters (78)
Breakthrough haemolysis (67)
Headache (66)
Product dose omission issue (59)
Uveitis (59)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which PEGCETACOPLAN Alternatives Have Lower Pulmonary embolism Risk?
PEGCETACOPLAN vs PEGFILGRASTIM
PEGCETACOPLAN vs PEGFILGRASTIM-APGF
PEGCETACOPLAN vs PEGFILGRASTIM-BMEZ
PEGCETACOPLAN vs PEGFILGRASTIM-CBQV
PEGCETACOPLAN vs PEGFILGRASTIM-JMDB